Immunosuppressive Agents: all 5,940 studies that test it
Page 41 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT01791088Phase 1
- First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02CompletedNCT01790737Phase 2
- Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host DiseaseCompletedNCT01788501Phase 2/3
- A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma PatientsStatus unknownNCT01788137Phase 3
- Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's MacroglobulinemiaCompletedNCT01788020Phase 3
- Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01787474Phase 1
- Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin LymphomasStatus unknownNCT01786018Phase 2
- Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal CancerTerminatedNCT01784978Phase 2
- Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS MetastasisCompletedNCT01783756Phase 1/2
- An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic DermatitisCompletedNCT01782729Phase 4
- Pharmacokinetic of Everolimus and Atorvastatin Co-administrationCompletedNCT01780948Not applicable
- A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant RecipientsCompletedNCT01780844Phase 2
- ADAPT - Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast CancerCompletedNCT01779206Phase 2/3
- PRevention of Macular EDema After Cataract SurgeryCompletedNCT01774474Phase 3
- Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and ExemestaneTerminatedNCT01773460Phase 3
- Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension GroupCompletedNCT01768312Phase 3
- Efficacy and Safety of Intralesional Corticosterois in the Treatment of VitiligoStatus unknownNCT01766609Phase 2
- the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia PatientStatus unknownNCT01766375Phase 3
- A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic SyndromeCompletedNCT01763580Phase 4
- Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous NephropathyWithdrawnNCT01762852Phase 2
- The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 DiabetesWithdrawnNCT01762657Phase 3
- The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes PatientsWithdrawnNCT01762644Phase 3
- Dose Adjusted EPOCH-R, to Treat Mature B Cell MalignanciesCompletedNCT01760226Early Phase 1
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)Status unknownNCT01760096Phase 2
- Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic AnemiaStatus unknownNCT01759732Phase 2
- A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX TherapyStatus unknownNCT01758666Not applicable
- Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT01758328Phase 1
- Abatacept Post-marketing Clinical Study in JapanCompletedNCT01758198Phase 4
- Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA NephropathyStatus unknownNCT01758120Phase 4
- ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic TumorsCompletedNCT01756989Phase 2
- Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple SclerosisTerminatedNCT01755871Phase 4
- Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas DiseaseCompletedNCT01755403Phase 4
- A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT01754805Phase 1
- Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD ProphylaxisTerminatedNCT01749111Phase 3
- CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell LymphomaStatus unknownNCT01746992Phase 4
- Efficacy and Safety Study of Tacrobell to Treat Rheumatoid ArthritisCompletedNCT01746680Phase 4
- Preventive Treatment of Tacrolimus Ointment in Children With Atopic DermatitisCompletedNCT01745159Phase 4
- Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)Status unknownNCT01744470Phase 4
- A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal RecipientsCompletedNCT01742676Phase 4
- Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the TransplantationCompletedNCT01742624Phase 4
- The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial)Status unknownNCT01741558Phase 2
- Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot StudyCompletedNCT01737671Early Phase 1
- An Investigator-Initiated Study to Assess the Cooling Effect of Triamcinolone Acetonide Aerosol When Used for Steroid-Responsive DermatosesCompletedNCT01736670Not applicable
- Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung CancerWithdrawnNCT01731587Phase 1
- Limitation of Ischemic Injury of a Kidney Stored in Machine Perfusion in Hypothermia - Evaluation of the Impact on Kidney Allograft FunctionCompletedNCT01731457Phase 2
- Sequential Therapy in Metastatic Renal Cell CarinomaCompletedNCT01731158Phase 2
- Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue SyndromeTerminatedNCT01730495Phase 2
- Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis ComplexStatus unknownNCT01730209Phase 2/3
- The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand ThymectomyCompletedNCT01727193Phase 3
- LAS41008 in Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01726933Phase 3
- Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®CompletedNCT01725620Phase 1
- Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week TrialCompletedNCT01718951Phase 4
- A Study to Assess the Effects of Cyclosporine on the Pharmacokinetics and Safety of Canagliflozin (JNJ-28431754) in Healthy VolunteersCompletedNCT01718652Phase 1
- Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid ArthritisWithdrawnNCT01717846Phase 4
- Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced SarcomasCompletedNCT01716689Phase 2
- Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's DiseaseCompletedNCT01716637Phase 1
- Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With EverolimusCompletedNCT01715935Phase 2
- Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal CancerCompletedNCT01714765Phase 1
- A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis StudyCompletedNCT01711814Phase 2
- A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RAStatus unknownNCT01709760Phase 3
- The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver TransplantationCompletedNCT01707849Phase 3
- Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of TransplantationCompletedNCT01706471Phase 4
- Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular RiskCompletedNCT01702207Phase 4
- Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT01701323Phase 1
- Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung CancerCompletedNCT01700400Phase 1
- The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant RecipientsStatus unknownNCT01699360Phase 4
- Generic Tacrolimus in the Elderly - Prograf® vs Tacni®CompletedNCT01698541Phase 4
- PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast CancerTerminatedNCT01697293Phase 1/2
- Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting ConditionsCompletedNCT01697020Phase 1
- A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's SyndromeCompletedNCT01693640Early Phase 1
- Low Dose Cyclosporin A in Primary Sjögren SyndromeCompletedNCT01693393Phase 2
- A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy VolunteersCompletedNCT01692834Phase 1
- Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01689987Phase 1
- A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015KCompletedNCT01686217Phase 1
- Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue SarcomaCompletedNCT01684449Phase 1/2
- Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic LeukemiaCompletedNCT01681563Phase 2
- A Comparison of the Effects of Extended Release Tacrolimus (Advagraf®) vs. Immediate Release Tacrolimus (Prograf®) on Kidney Function in Healthy Male VolunteersCompletedNCT01681134Phase 1
- Sirolimus for Massive Polycystic LiverStatus unknownNCT01680250Phase 2/3
- High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior TreatmentTerminatedNCT01679041Phase 2
- Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas DiseaseCompletedNCT01678599Phase 4
- Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute LeukemiaWithdrawnNCT01677949Phase 2
- Intravitreal Injections of Sirolimus in the Treatment of Geographic AtrophyTerminatedNCT01675947Phase 2
- Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid TumorsCompletedNCT01670175Phase 1
- Maintenance Metronomic Chemotherapy for Metastatic Colorectal CarcinomaTerminatedNCT01668680Phase 2
- Effects of the Use of "de Novo" Everolimus in Renal Tranplant PopulationStatus unknownNCT01663805Phase 4
- Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid TumorsCompletedNCT01661400Phase 1
- A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed MyelomaCompletedNCT01660750Phase 1
- Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis CongenitaActive, not recruitingNCT01659606Phase 2
- Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging StudyTerminatedNCT01659242Phase 4
- Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT01658319Phase 1
- Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/LymphomaTerminatedNCT01658007Early Phase 1
- Methotrexate in Symptomatic Knee OsteoarthritisCompletedNCT01654575Not applicable
- CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)CompletedNCT01653717Phase 1
- Certican (Everolimus) for Recipients of Kidney From HLA-identical Living DonorsCompletedNCT01653041Phase 4
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune DeficienciesActive, not recruitingNCT01652092Not applicable
- CYCLosporinE A in Reperfused Acute Myocardial InfarctionCompletedNCT01650662Phase 3
- A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis SubjectsCompletedNCT01649999Phase 2
- Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) TrialCompletedNCT01649960Phase 1
- Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine TumorsTerminatedNCT01648465Phase 2
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal HemoglobinuriaStatus unknownNCT01642979Phase 2